Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jun Wei
Affiliation
The University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
2004
Papers
51
H Index
32
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35914692
Acoustically accelerated neural differentiation of human embryonic stem cells.
Acta Biomater
2022
35433114
Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system.
Oncoimmunology
2022
35575067
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
CNS Oncol
2022
34138753
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.
J Clin Invest
2021
34532286
Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment.
Front Oncol
2021
34031054
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
Clin Cancer Res
2021
32567735
Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
EMBO J
2020
31679017
Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.
Neuro Oncol
2020
33348707
MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme.
Cancers (Basel)
2020
32605912
Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.
Clin Cancer Res
2020
32721947
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.
JCI Insight
2020
32554515
Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
Clin Cancer Res
2020
30307407
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
J Clin Invest
2019
28965162
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
J Neurooncol
2018
29869738
Rethinking medulloblastoma from a targeted therapeutics perspective.
J Neurooncol
2018
29632728
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
Oncoimmunology
2018
27765835
Immune modulatory nanoparticle therapeutics for intracerebral glioma.
Neuro Oncol
2017
26973881
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
JCI Insight
2016
26658052
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
Neuro Oncol
2016
26323609
PD-L1 expression and prognostic impact in glioblastoma.
Neuro Oncol
2016
27376157
MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.
J Gene Ther
2016
25619840
C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy.
Oncogene
2015
27467917
Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression.
Oncoimmunology
2015
24974128
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
J Natl Cancer Inst
2014
25465288
Therapeutic targets in subependymoma.
J Neuroimmunol
2014
23636127
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Cancer Res
2013
24409449
Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.
Cancer Immunol Res
2013
24083077
MicroRNAs as novel immunotherapeutics.
Oncoimmunology
2013
23983766
The controversial role of microglia in malignant gliomas.
Clin Dev Immunol
2013
21792892
The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.
Int J Cancer
2012
23013619
Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
Oncotarget
2012
22753228
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Neuro Oncol
2012
21490182
Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.
Clin Cancer Res
2011
22468222
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.
Clin Investig (Lond)
2011
21283755
Hypoxia potentiates glioma-mediated immunosuppression.
PLoS One
2011
20053772
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
Mol Cancer Ther
2010
20737294
Immune therapeutic targeting of glioma cancer stem cells.
Target Oncol
2010
20921210
Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.
Clin Cancer Res
2010
20667896
Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
Neuro Oncol
2010
20388845
Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.
Clin Cancer Res
2010
19944972
The role of tregs in glioma-mediated immunosuppression: potential target for intervention.
Neurosurg Clin N Am
2010
20068105
Glioma-associated cancer-initiating cells induce immunosuppression.
Clin Cancer Res
2010
18594817
Topotecan enhances immune clearance of gliomas.
Cancer Immunol Immunother
2009
20214040
The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Clin Neurosurg
2009
19900287
yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.
J Transl Med
2009
19002459
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
Cancer Immunol Immunother
2009
18794085
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
Clin Cancer Res
2008
19088040
The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
Clin Cancer Res
2008
17978190
Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.
Proc Natl Acad Sci U S A
2007
15712204
Novel spatiotemporal patterns of epithelial tumor invasion in Drosophila discs large egg chambers.
Dev Dyn
2005
1 - 50 of 51
Column Actions
Search
Recommended Authors
Olivia Singh
Princess Margaret Cancer Centre
Career Start Year
2016
Number of shared co-authors
7
Nazanin Tatari
McMaster University
Career Start Year
2015
Number of shared co-authors
0
Chirayu Chokshi
McMaster University
Career Start Year
2015
Number of shared co-authors
0
Andrew X Chen
Columbia University
Career Start Year
2014
Number of shared co-authors
2
Jin-Ku Lee
Seoul National University, College of Medicine
Career Start Year
2010
Number of shared co-authors
1
Miaojun Han
Department of Research and Development, Shanghai United Imaging Intelligence Co.
Career Start Year
2010
Number of shared co-authors
0
Huiyuan Zhang
Texas Children's Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Tobias Weiss
Westlake University
Career Start Year
2009
Number of shared co-authors
0
Jianying Zhang
City of Hope National Medical Center
Career Start Year
2009
Number of shared co-authors
0
Jonas Kloepper
University of Lausanne
Career Start Year
2008
Number of shared co-authors
0
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year
2007
Number of shared co-authors
0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year
2006
Number of shared co-authors
0
Catherine P Langford
University of Alabama at Birmingham
Career Start Year
2005
Number of shared co-authors
0
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year
2004
Number of shared co-authors
2
Gavin P Dunn
Washington University School of Medicine
Career Start Year
2002
Number of shared co-authors
4
Johanna Buchroithner
Johannes Kepler University
Career Start Year
2001
Number of shared co-authors
0
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
6
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year
1999
Number of shared co-authors
0
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
1998
Number of shared co-authors
5
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year
1996
Number of shared co-authors
10
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year
1996
Number of shared co-authors
8
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year
1996
Number of shared co-authors
4
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
15
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year
1992
Number of shared co-authors
4
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year
1991
Number of shared co-authors
2
Howard A Fine
Meyer Cancer Center
Career Start Year
1990
Number of shared co-authors
4
Michael Weller
University Hospital and University of Zurich
Career Start Year
1987
Number of shared co-authors
10
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year
1985
Number of shared co-authors
1
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year
1984
Number of shared co-authors
10
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year
1970
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers
46
Ling-Yuan Kong
The University of Texas MD Anderson Cancer Center
Co-authored papers
28
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers
23
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
17
Waldemar Priebe
The University of Texas MD Anderson Cancer Center
Co-authored papers
14
Qingyi Wei
South China University of Technology
Co-authored papers
14
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers
13
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
6
Tiffany Doucette
Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
Co-authored papers
6
John F de Groot
Co-authored papers
5
Yuhui Yang
Xuanwu Hospital, Capital Medical University
Co-authored papers
4
Jason T Huse
Co-authored papers
4
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers
3
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Co-authored papers
3
Erik P Sulman
NYU Grossman School of Medicine
Co-authored papers
3
Kenneth Aldape
National Cancer Institute
Co-authored papers
2
Verlene Henry
The MD Anderson Cancer Center
Co-authored papers
2
Khatri Latha
Baylor College of Medicine
Co-authored papers
2
Howard Colman
Huntsman Cancer Institute, University of Utah
Co-authored papers
2
Juan Fueyo
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
1
Jinbo Yang
School of Medicine and Pharmacy, Ocean University of China
Co-authored papers
1
Marta M Alonso
CIMA-Universidad de Navarra
Co-authored papers
1
Rivka R Colen
Co-authored papers
1
Rebecca A Harrison
Co-authored papers
1
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers
1
Kevin Beccaria
Hopital Universitaire Necker-Enfants Malades
Co-authored papers
1
Candelaria Gomez-Manzano
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
1
Annette M Molinaro
Co-authored papers
1
1 - 30